38 filings
Page 2 of 2
8-K
w1o6r83alnv 1j
5 Jan 23
Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
7:14am
8-K/A
fupx4tkoj8jz lh1
27 Dec 22
Entry into a Material Definitive Agreement
9:19am
8-K
7usc3
23 Dec 22
Entry into a Material Definitive Agreement
4:12pm
8-K
itghvl3r
10 Nov 22
Akili Reports Third Quarter 2022 Financial Results and Company Update
4:08pm
8-K
hjum j449rw2vlf66h
27 Oct 22
Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors
7:10am
8-K
l9t q5jfcd
17 Oct 22
Regulation FD Disclosure
4:22pm
8-K
og3fa778 7vj0b
24 Aug 22
Regulation FD Disclosure
5:37pm
8-K
5t5 cxmy6
23 Aug 22
Index to Financial Statements
4:45pm
8-K
1kq0 6lc98e1kb1
19 Aug 22
Departure of Directors or Certain Officers
5:28pm
8-K
hm1t23f2wec36
8 Jul 22
Departure of Directors or Certain Officers
5:23pm
8-K/A
l7fjy 9xrzeqcy
20 May 22
Other Events
5:01pm
8-K
wci npxv2urmm3gwls
22 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K/A
mr22 ef5g
27 Jan 22
Entry into a Material Definitive Agreement
9:21am
8-K
3mttj1a6dr5dqg34h
26 Jan 22
Entry into a Material Definitive Agreement
7:11am
8-K
jrj6vhlvogp
16 Nov 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:34pm
8-K
21pw 9m6q4wds6f36
24 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
iy9crbs41egube
9 Jul 21
Other Events
6:03am
8-K
bvtyw2w0 23h9y
2 Jul 21
Social Capital Suvretta Holdings Corp. I Announces Pricing of Upsized $220,000,000 Initial Public Offering
4:19pm